Multidisciplinary in content and scope, the 2017 Gastrointestinal (GI) Cancers Symposium brings together a diverse group of stakeholders involved in the prevention, detection, and treatment of GI cancers. The meeting’s intimate and interactive setting facilitates a forum for networking and discussion to exchange ideas, best practices, and science that will lead to future progress. All educational sessions will engage attendees through the use of eQ&A, in which questions may be sent via text, tweet, or website submission. Each day, Keynote Sessions will highlight the most up-to-date science and clinical practice for the various disease sites.
New for 2017, attendees need their username and password to access the CME Portal. If you do not know your username or password, you may use your email address to retrieve them. If you do not know the email address associated with your account, please contact
- Onsite: ASCO staff at the Tech Help Desk in the Posters, Exhibits, and Food Service Room or at the Registration and Customer Service Desk.
- Off-site: ASCO Customer Service from 8:30 AM - 5:00 PM (ET) at email@example.com, 888-282-2552 or 703-299-0158.
Accreditation and Designation Statement
In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Society of Clinical Oncology designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other attendees may request a Certificate of Participation after submitting their session participation. Please note that all final decisions regarding certificate acceptance toward any licensure requirements will be made by the licensing organization to which the certificate is submitted.
Educational Needs Statement
The 2017 Gastrointestinal Cancers Symposium—Multidisciplinary Precision Care: Progress and Innovation allows health care providers across multiple disciplines to receive critical updates and recommendations to improve the care of patients diagnosed with these diseases based on new and emerging options for diagnostic and therapeutic approaches. Although the incidence and mortality rate of these diseases continue to increase, new evidence in the use of molecular markers and immunotherapy is enabling improvements in precision care through innovative and progressive therapy options for patients. Additionally, advances in radiation and surgical techniques reinforce the importance of a multidisciplinary approach to care. Thus, ongoing education in this field is an ever-evolving need to ensure clinicians are kept up-to-date on emerging therapies and cutting-edge technology to enable a proper consideration of these options and their potential for integration into current standards of care.
This program is also designed to provide opportunities for learners to interact with expert faculty of varying disciplines in both the sessions and in active networking events. These dialogues further equip health care providers to deliver optimal care for their patients diagnosed with gastrointestinal cancers.
This symposium is designed for physicians and researchers interested in the prevention, screening, evaluation, and management of gastrointestinal cancers, including, but not limited to medical, surgical, and radiation oncologists; pathologists; radiologists; and other translational-oriented laboratory scientists.
This symposium may also benefit nurses, pharmacists, physician assistants, and other health care professionals involved in clinical cancer care and cancer research.
Learning Objectives and Competencies
Upon participation in this activity, attendees will be better able to
- Review the advances in diagnostic procedures that could improve treatment decisions for patients with esophageal and gastric cancer.
- Compare and contrast multidisciplinary perspectives on the use of multimodality management for patients with esophageal squamous cell carcinoma.
- Evaluate the risks and benefits of technologies used internationally that could enhance the therapy options for patients with pancreatic cancer.
- Assess how transplantation, immunotherapy, and multimodal therapy could be used to improve outcomes for patients with hepatobiliary cancers.
- Improve ability to select appropriate treatment for patients with neuroendocrine tumors and gastrointestinal cancers, and identify the importance of a multidisciplinary approach to care.
- Examine the role of molecular markers, genetic testing and molecular subtypes to more accurately screen for colorectal cancers and assess hereditary and general risk.
- Incorporate cancer subtypes and staging in the development of appropriate treatment plans for patients with rectal cancer.
This activity was planned in the context of the following attributes
|Institute of Medicine (IOM) Competencies||Accreditation Council for Graduate Medical Education (ACGME) Core Competencies|
Disclaimer and Unlabeled Usage Statement
The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Symposium Cosponsors and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.
ASCO and the Conquer Cancer Foundation gratefully acknowledge the following companies for their support of the 2017 ASCO Immuno-Oncology Symposium:
|Celgene Corporation||Genentech BioOncology™|
|Incyte||Merck & Co., Inc.|
|Novartis Oncology||Pfizer Oncology|
Attendees can log in to the iPlanner or CE Portal to access any of the following certificates after noting their participation:
- Continuing Medical Education Certificate – available for physicians who would like to receive CME credits for their participation at the Symposium
- Certificate of Participation – all other attendees may request a Certificate of Participation after submitting their session participation. Please note that all final decisions regarding certificate acceptance toward any licensure requirements will be made by the licensing organization to which the certificate is submitted.
- Certificate of Attendance – Attendees can download a Certificate of Attendance from the Attendee Resource Center if they need a record of their attendance at the Symposium but do not require documentation for continuing education purposes. Please note that this certificate does not award any continuing education credits.
For instructions on how to claim credit and access certificates, please see the ‘Symposium Feedback and Credit Claim Instructions’ section.
Symposium Feedback and Credit Claim Instructions
Every participant is encouraged to submit a Symposium Feedback Form, provide session ratings, and access certificates for the Symposium through the iPlanner app. Your feedback is utilized by leadership to enhance programs, develop new initiatives, gauge educational impact, and plan for future meetings.
- To provide feedback on a specific session
- Download the iPlanner app
- Select a session by searching by time or track
- Select “Rate This Session” to submit feedback on each session you attend
- To access certificates and claim credit
- Log in to the CE Portal
- using your ASCO.org username and password
- Select a session by searching by time or keyword
- Select “Claim More Credits” to claim CE credits and access your certificate
- To give overall feedback on the meeting
- Submit a Symposium Feedback Form
To receive ABIM MOC, participants must submit their Symposium Feedback Form, available on the iPlanner, and claim their CME credits for the Symposium by February 23, 2017. Once both of these steps are complete, ASCO will transmit all information to ABIM on the participant’s behalf.